TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 17)

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 MARKET SCOPE

1.3.1 MARKETS COVERED

1.3.2 YEARS CONSIDERED FOR THE STUDY

1.4 CURRENCY

1.5 LIMITATIONS

1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 20)

2.1 RESEARCH DATA

2.1.1 SECONDARY DATA

2.1.1.1 Key data from secondary sources

2.1.2 PRIMARY DATA

2.2 MARKET SIZE ESTIMATION

2.2.1 BOTTOM-UP APPROACH

2.2.2 GROWTH FORECAST

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

3 EXECUTIVE SUMMARY (Page No. - 26)

4 PREMIUM INSIGHTS (Page No. - 30)

4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE AUTOIMMUNE DISEASE DIAGNOSIS MARKET

4.2 ASIA PACIFIC MARKET: BY DISEASE

4.3 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW (Page No. - 33)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

5.2.1 DRIVERS

5.2.1.1 High incidence and prevalence of autoimmune diseases

5.2.1.2 Increasing awareness about autoimmune diseases

5.2.1.3 Growth in the number of research activities on autoimmune diseases

5.2.2 RESTRAINTS

5.2.2.1 High capital requirements

5.2.3 OPPORTUNITIES

5.2.3.1 Use of biosensors for autoimmune disease diagnosis

5.2.4 TRENDS

5.2.4.1 Growth in the number of reagent rental agreements

6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT (Page No. - 38)

6.1 INTRODUCTION

6.2 CONSUMABLES & ASSAY KITS

6.2.1 NEED FOR THE RAPID DETECTION OF AUTOIMMUNE DISEASES TO DRIVE THE DEMAND FOR CONSUMABLES AND ASSAY KITS

6.3 INSTRUMENTS

6.3.1 INSTRUMENTS SEGMENT TO RECORD SIGNIFICANT GROWTH DURING THE FORECAST PERIOD

7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE (Page No. - 42)

7.1 INTRODUCTION

7.2 ROUTINE LABORATORY TESTS

7.2.1 RISING NUMBER OF ROUTINE HEALTH CHECK-UPS TO SUPPORT MARKET GROWTH

7.3 INFLAMMATORY MARKERS

7.3.1 ABILITY OF INFLAMMATORY MARKERS TO DETECT ABNORMALITIES EFFICIENTLY TO DRIVE THEIR DEMAND

7.4 AUTOANTIBODIES AND IMMUNOLOGIC TESTS

7.4.1 ADOPTION OF NOVEL IMMUNOLOGY TESTS TO DRIVE MARKET GROWTH

7.5 OTHER TESTS

8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE (Page No. - 47)

8.1 INTRODUCTION

8.2 RHEUMATOID ARTHRITIS

8.2.1 INCREASING INCIDENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH

8.3 SYSTEMIC LUPUS ERYTHEMATOSUS

8.3.1 RISING PREVALENCE OF LUPUS TO SUPPORT MARKET GROWTH

8.4 SJ�GREN�S SYNDROME

8.4.1 RISING AWARENESS REGARDING SJ�GREN�S SYNDROME TO SUPPORT MARKET GROWTH

8.5 THYROIDITIS

8.5.1 RISING PREVALENCE OF THYROID DISORDERS TO DRIVE MARKET GROWTH

8.6 SCLERODERMA

8.6.1 INCREASING INCIDENCE OF SKIN DISORDERS TO DRIVE MARKET GROWTH

8.7 OTHER DISEASES

9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER (Page No. - 54)

9.1 INTRODUCTION

9.2 CLINICAL LABORATORIES

9.2.1 INCREASING INCIDENCE OF AUTOIMMUNE DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES

9.3 HOSPITALS

9.3.1 INCREASING GOVERNMENT INITIATIVES TO PROVIDE QUALITY TREATMENT FOR AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH

9.4 OTHER END USERS

10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION (Page No. - 58)

10.1 INTRODUCTION

10.2 NORTH AMERICA

10.2.1 US

10.2.1.1 Rising expenditure on autoimmune disease R&D to drive market growth in the US

10.2.2 CANADA

10.2.2.1 Rising prevalence of autoimmune diseases to support market growth

10.3 EUROPE

10.3.1 GERMANY

10.3.1.1 Rising healthcare expenditure to drive market growth in Germany

10.3.2 UK

10.3.2.1 Rising prevalence of autoimmune diseases to drive market growth in the UK

10.3.3 FRANCE

10.3.3.1 High prevalence of multiple sclerosis to drive market growth in France

10.3.4 ITALY

10.3.4.1 Increasing life science R&D expenditure to support market growth in Italy

10.3.5 SPAIN

10.3.5.1 Research activities conducted in the country to drive market growth in Spain

10.3.6 REST OF EUROPE

10.4 ASIA PACIFIC

10.4.1 CHINA

10.4.1.1 Outbreak of COVID-19 to hamper market growth during the forecast period

10.4.2 INDIA

10.4.2.1 Development of antibody tests to support market growth in India

10.4.3 JAPAN

10.4.3.1 Rising healthcare expenditure to support market growth in Japan

10.4.4 AUSTRALIA

10.4.4.1 Rising prevalence of autoimmune diseases to drive market growth in Australia

10.4.5 REST OF ASIA PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST AND AFRICA

10.6 LATIN AMERICA

10.6.1 HIGH PREVALENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH IN LATIN AMERICA

11 COMPETITIVE LANDSCAPE (Page No. - 94)

11.1 OVERVIEW

11.2 MARKET SHARE ANALYSIS, 2018

11.3 COMPETITIVE SCENARIO

11.3.1 PRODUCT LAUNCHES (2017-2020)

11.3.2 PRODUCT APPROVALS (2017-2020)

11.3.3 PARTNERSHIPS

11.3.4 ACQUISITIONS (2017-2020)

11.3.5 COLLABORATIONS (2017-2020)

11.4 COMPETITIVE LEADERSHIP MAPPING (2018)

11.4.1 VISIONARY LEADERS

11.4.2 INNOVATORS

11.4.3 DYNAMIC DIFFERENTIATORS

11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES (Page No. - 101)

(Business Overview, Products Offered, Recent Developments, and MnM View)*

12.1 THERMO FISHER SCIENTIFIC

12.2 SIEMENS

12.3 ABBOTT

12.4 DANAHER

12.5 BIO-RAD LABORATORIES

12.6 GRIFOLS

12.7 TRINITY BIOTECH

12.8 WERFEN

12.9 HYCOR BIOMEDICAL

12.10 EUROIMMUN

12.11 ONCIMMUNE

12.12 HTG MOLECULAR DIAGNOSTICS, INC.

12.13 SERAMUN DIAGNOSTICA GMBH

12.14 EXAGEN INC.

12.15 CAMBRIDGE LIFE SCIENCES LIMITED

12.16 A. MENARINI DIAGNOSTICS S.R.L

12.17 ORGENTEC DIAGNOSTIKA

12.18 KRONUS

12.19 ERBA GROUP

12.20 AESKU.GROUP GMBH & CO. KG

* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 143)

13.1 INSIGHTS FROM INDUSTRY EXPERTS

13.2 DISCUSSION GUIDE

13.3 KNOWLEDGE STORE: MARKETSANDMARKETS� SUBSCRIPTION PORTAL

13.4 AVAILABLE CUSTOMIZATIONS

13.5 RELATED REPORTS

13.6 AUTHOR DETAILS



LIST OF TABLES (96 Tables)

TABLE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 2 AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES & ASSAY KITS MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 3 AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 5 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2018�2025 (USD MILLION)

TABLE 6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS, BY REGION, 2018�2025 (USD MILLION)

TABLE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2018�2025 (USD MILLION)

TABLE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2018�2025 (USD MILLION)

TABLE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2018�2025 (USD MILLION)

TABLE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018�2025 (USD MILLION)

TABLE 12 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJ�GREN�S SYNDROME, BY REGION, 2018�2025 (USD MILLION)

TABLE 13 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION, 2018�2025 (USD MILLION)

TABLE 14 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2018�2025 (USD MILLION)

TABLE 15 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2018�2025 (USD MILLION)

TABLE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,2018�2025 (USD MILLION)

TABLE 17 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018�2025 (USD MILLION)

TABLE 18 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, 2018�2025 (USD MILLION)

TABLE 19 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2018�2025 (USD MILLION)

TABLE 20 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2018�2025 (USD MILLION)

TABLE 21 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 23 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 24 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 25 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 26 EXPENDITURE ON AUTOIMMUNE DISEASE R&D BY THE NATIONAL INSTITUTES OF HEALTH, 2016�2019

TABLE 27 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 28 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE,2018�2025 (USD MILLION)

TABLE 29 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 30 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 31 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 32 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 33 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 34 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 35 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 36 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT,2018�2025 (USD MILLION)

TABLE 37 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 38 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 39 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER,2018�2025 (USD MILLION)

TABLE 40 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 41 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 42 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 43 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 44 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 45 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 46 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 47 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 48 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 49 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 50 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 51 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 52 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 53 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 54 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 55 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 56 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 57 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 58 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 59 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 60 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 61 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 62 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 63 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 64 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018�2025 (USD MILLION)

TABLE 65 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 66 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 67 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE,2018�2025 (USD MILLION)

TABLE 68 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 69 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 70 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 71 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 72 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 73 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 74 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 75 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 76 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 77 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 78 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 79 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 80 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 81 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 82 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 83 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 84 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 85 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 86 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 87 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 88 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 89 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 90 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 91 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 92 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)

TABLE 93 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018�2025 (USD MILLION)

TABLE 94 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018�2025 (USD MILLION)

TABLE 95 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018�2025 (USD MILLION)

TABLE 96 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018�2025 (USD MILLION)



LIST OF FIGURES (34 Figures)

FIGURE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION

FIGURE 2 RESEARCH DESIGN

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION

FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH

FIGURE 5 MARKET SIZE ESTIMATION FROM THE PARENT MARKET

FIGURE 6 DATA TRIANGULATION METHODOLOGY

FIGURE 7 ASSUMPTIONS FOR THE STUDY

FIGURE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)

FIGURE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION)

FIGURE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)

FIGURE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)

FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET

FIGURE 13 HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD

FIGURE 14 RHEUMATOID ARTHRITIS SEGMENT DOMINATED THE APAC MARKET IN 2019

FIGURE 15 JAPAN TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

FIGURE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS

FIGURE 17 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT

FIGURE 18 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT

FIGURE 19 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT

FIGURE 20 PRODUCT LAUNCHES�THE MOST ADOPTED GROWTH STRATEGY FROM 2017 TO 2020

FIGURE 21 SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET (2018)

FIGURE 22 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2018

FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

FIGURE 24 SIEMENS: COMPANY SNAPSHOT

FIGURE 25 ABBOTT: COMPANY SNAPSHOT

FIGURE 26 DANAHER: COMPANY SNAPSHOT

FIGURE 27 BIO-RAD LABORATORIES: COMPANY SNAPSHOT

FIGURE 28 GRIFOLS: COMPANY SNAPSHOT

FIGURE 29 TRINITY BIOTECH: COMPANY SNAPSHOT

FIGURE 30 WERFEN: COMPANY SNAPSHOT

FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT

FIGURE 32 ONCIMMUNE: COMPANY SNAPSHOT

FIGURE 33 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY SNAPSHOT

FIGURE 34 EXAGEN INC.: COMPANY SNAPSHOT